Daily Archives: May 4, 2017

A Patient With AIDS and an Unusual Cause of Jaundice

Question: A 59-year-old man presented to the clinic with 5 days of right upper quadrant abdominal pain, pruritus, and scleral icterus. The pain was constant, dull, nonradiating, and not associated with fever or rigors. His medical history pertinent for… Continue reading

Posted in News | Comments Off on A Patient With AIDS and an Unusual Cause of Jaundice

Obituary: The Impact of Thomas Earl Starzl, MD, PhD

“Tis after death that we measure men”—James Barron Hope Continue reading

Posted in News | Comments Off on Obituary: The Impact of Thomas Earl Starzl, MD, PhD

Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis

Primary myelofibrosis is a form of myeloproliferative neoplasm characterized by stem-cell derived clonal proliferation, resulting in bone marrow fibrosis, splenomegaly and extramedullary haematopoiesis, with portal hypertension (PHT) occuring in 10%–… Continue reading

Posted in News | Comments Off on Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis

Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood–Brain Barrier Drug Transport

We read with interest the article by Tsai et al1 in a recent issue of Gastroenterology, which highlights the influence of proton pump inhibitors (PPIs) use on encephalopathy occurrence in cirrhotic patients. This case control study performed in a larg… Continue reading

Posted in News | Comments Off on Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood–Brain Barrier Drug Transport